1. Deuterium‐Stabilized (R)‐Pioglitazone (PXL065) Is Responsible for Pioglitazone Efficacy in NASH yet Exhibits Little to No PPARγ Activity. Issue 8 (10th April 2021) Authors: Jacques, Vincent; Bolze, Sébastien; Hallakou‐Bozec, Sophie; Czarnik, Anthony W.; Divakaruni, Ajit S.; Fouqueray, Pascale; Murphy, Anne N.; Van der Ploeg, Lex H.T.; DeWitt, Sheila Journal: Hepatology communications Issue: Volume 5:Issue 8(2021) Page Start: 1412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of imeglimin add‐on to insulin monotherapy in Japanese patients with type 2 diabetes (TIMES 3): A randomized, double‐blind, placebo‐controlled phase 3 trial with a 36‐week open‐label extension period. Issue 5 (8th February 2022) Authors: Reilhac, Caroline; Dubourg, Julie; Thang, Carole; Grouin, Jean‐Marie; Fouqueray, Pascale; Watada, Hirotaka Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 5(2022) Page Start: 838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of imeglimin in Japanese patients with type 2 diabetes: A 24‐week, randomized, double‐blind, placebo‐controlled, dose‐ranging phase 2b trial. Issue 3 (13th January 2021) Authors: Dubourg, Julie; Ueki, Kohjiro; Grouin, Jean‐Marie; Fouqueray, Pascale Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 3(2021) Page Start: 800 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo-controlled, phase 2a study. (November 2021) Authors: Cusi, Kenneth; Alkhouri, Naim; Harrison, Stephen A; Fouqueray, Pascale; Moller, David E; Hallakou-Bozec, Sophie; Bolze, Sebastien; Grouin, Jean-Marie; Jeannin Megnien, Sophie; Dubourg, Julie; Ratziu, Vlad Journal: Lancet gastroenterology and hepatology Issue: Volume 6:Number 11(2021) Page Start: 889 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long‐term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): A 52‐week, open‐label, multicentre phase 3 trial. Issue 4 (27th December 2021) Authors: Dubourg, Julie; Fouqueray, Pascale; Quinslot, Damien; Grouin, Jean‐Marie; Kaku, Kohei Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 4(2022) Page Start: 609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes. Issue 3 (29th December 2020) Authors: Hallakou‐Bozec, Sophie; Vial, Guillaume; Kergoat, Micheline; Fouqueray, Pascale; Bolze, Sébastien; Borel, Anne‐Laure; Fontaine, Eric; Moller, David E. Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 3(2021) Page Start: 664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase 2 trial with imeglimin in patients with Type 2 diabetes indicates effects on insulin secretion and sensitivity. Issue 6 (14th October 2022) Authors: Theurey, Pierre; Thang, Carole; Pirags, Valdis; Mari, Andrea; Pacini, Giovanni; Bolze, Sébastien; Hallakou‐Bozec, Sophie; Fouqueray, Pascale Journal: Endocrinology, diabetes & metabolism Issue: Volume 5:Issue 6(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Reduced lactic acidosis risk with Imeglimin: Comparison with Metformin. Issue 5 (11th March 2022) Authors: Theurey, Pierre; Vial, Guillaume; Fontaine, Eric; Monternier, Pierre‐Axel; Fouqueray, Pascale; Bolze, Sébastien; Moller, David E.; Hallakou‐Bozec, Sophie Journal: Physiological reports Issue: Volume 10:Issue 5(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗